2026 Supplement Trends: What’s Actually Selling, Not Just What’s Hyped
The gap between what trends on social media and what reorders from a factory is where brands lose money. A viral ingredient can generate a spike in samples and nothing in repeat orders; a boring category can quietly compound. This page separates the two, based on what buyers actually order, and what that means for your next launch.
On this page: What Is Actually Selling · What the Hype Misses · What to Do With This
What Is Actually Selling
- Which categories are genuinely growing?
The dependable ones: sleep and relaxation, gut health, women’s health, sports recovery and everyday multivitamin-style products. These generate repeat purchase, which is what makes a brand viable. They are less exciting than a viral ingredient and far more profitable. - What is happening to gummies?
Continued growth, but splitting. The mass-market gummy is commoditising on price, while functional gummies — high-dose, sugar-free, targeted — are where the margin has moved. Being in gummies is no longer a differentiator; being in a specific functional gummy is. - Which formats are growing fastest?
Stick packs and powder sachets, driven by convenience and by electrolyte and functional-beverage positioning. They are also cheaper to ship per serving than a bottle, which supports direct-to-consumer economics. - What about the viral ingredients?
Shilajit, sea moss and similar actives generate real demand but also real scepticism, and repeat purchase is weaker than in established categories. They work as an entry product; the brand survives on what the customer buys next.
What the Hype Misses
- Why does hype not equal sales?
Hype drives a first purchase, not a second one. A product that does not deliver a perceptible benefit sells once. The categories that compound are those with a felt effect or a habitual use occasion. - What is the most common launch mistake?
Choosing an ingredient because it trends rather than because it has a repeat-purchase reason to exist. The launch performs, the reorder does not arrive, and the inventory is stuck. - Does premium positioning still work?
Yes, when it is attached to something the buyer can perceive — a cleaner label, a better format, a credible dose. Premium without a perceptible difference gets discounted back to the market price. - What about sustainability and transparency?
They are becoming a purchasing requirement in several markets, particularly in Europe, rather than a differentiator. Treat them as table stakes for those buyers and as a genuine advantage where competitors cannot document them.
What to Do With This
- How should I pick my first product?
Pick a category with a repeat-purchase reason and a format you can produce competitively. Launch there, prove the reorder, and use the viral ingredient as a traffic product rather than the foundation. - Where does margin come from?
From the second and third purchase, and from a format that is hard to commoditise. That usually means a specific format or a proven dose rather than a copied product. - How do I test cheaply?
Run a small batch in a stock formula, test it in market, and only commit to custom packaging once the reorder is real. The cost of testing is far lower than the cost of a wrong full run. - What should I ask a factory?
Ask what their clients actually reorder, not what is trending. A manufacturer sees the second purchase, and that view is more useful than any trend report.
Related Reading
See gummy manufacturing and sachet manufacturing for the two formats behind most of the current growth.
Want a Read on What Reorders?
Tell us the category and channel you are considering. We will tell you what our clients actually reorder in that space, what format they use, and where the margin sits.
- Firm unit price against your agreed specification
- Firm lead time confirmed with your quotation
- Samples in 7–10 working days for mature formulas
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
